What's new

Filters: policy
x
Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

Second wave pandemic preparedness: procurement principles

24 August 2020

Policy

Open

Policy Roadmap for Medicines Manufacturing Leadership

6 July 2020

Policy

Open

Call for tenders SANTE/2020/C3/29 for the supply of medicinal products used for intensive care patients subject to the novel coronavirus (COVID-19) disease – policy and technical concerns

25 June 2020

Policy

Open

Preparing for a potential second COVID-19 wave. Joint statement by Medicines for Europe and EFPIA with Kearney

22 June 2020

Policy

Open

LESSONS LEARNED FROM COVID-19 – POLICY PAPER

22 June 2020

Policy

Open

Position Paper. Incentives Review The Orphan and Paediatric Incentives

1 March 2020

Policy

Open

The secret to improve access to value added medicines

14 November 2019

Policy

Open

A digital future for value added medicines

24 September 2019

Policy, Report

Open

Calls to action to improve access to value added medicines

26 February 2019

Policy, Report

Open

Case Studies for Value Added Medicines. Unlocking the potential of patient-centric continuous innovation

26 February 2019

Policy, Report

Open

Subscribe to our newsletter